Advertisement

Clinical Implications of Pancreatic Cancer

  • Eirini V. Pantiora
  • Georgios P. Fragulidis
Chapter

Abstract

The dismal prognosis of patients with pancreatic cancer (PC) results from the combination of the aggressive biology of the disease along with the advanced stage at the time of diagnosis. Only 20% of patients with PC have a potentially resectable tumor at presentation. Delays in diagnosis are mainly due to subtle and nonspecific symptoms. Currently, the only potentially curative therapy for PC is surgical resection with an overall 5-year survival at 15–27%. Thus, timely detection of the disease can enable patients to undergo surgical resection with negative margin (R0) and maximize survival benefit. Patients who undergo incomplete resection have similar survival rates to those patients with metastatic disease and should be spared from an unnecessary surgery, as they will not have any benefit from surgical resection.

Therefore, accurate preoperative staging is of paramount importance, and cross-sectional imaging plays an essential role in both the diagnosis and appropriate staging of PC. Preoperative imaging in patients with PC is used to characterize patients as having resectable disease, borderline resectable disease, locally advanced disease (unresectable), and metastatic disease (unresectable).

References

  1. 1.
    Pietryga JA, Morgan DE (2015) Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol 6(4):343–357.  https://doi.org/10.3978/j.issn.2078-6891.2015.024 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lee ES, Lee JM (2014) Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol 20(24):7864–7877.  https://doi.org/10.3748/wjg.v20.i24.7864 CrossRefGoogle Scholar
  3. 3.
    Yeh R, Steinman J, Luk L, Kluger MD, Hecht EM (2017) Imaging of pancreatic cancer: what the surgeon wants to know. Clin Imaging 42(2017):203–217.  https://doi.org/10.1016/j.clinimag.2016.10.002 CrossRefGoogle Scholar
  4. 4.
    Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M (2011) Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990–2010. World J Gastroenterol 17(7):867–897.  https://doi.org/10.3748/wjg.v17.i7.867 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Buchs NC, Chilcott M, Poletti PA, Buhler LH, Morel P (2010) Vascular invasion in pancreatic cancer: imaging modalities, preoperative diagnosis and surgical management. World J Gastroenterol 16(7):818–831.  https://doi.org/10.3748/wjg.v16.i7.818 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Rabinowitz CB, Prabhakar HB, Sahani DV (2008) Recent advances in imaging of pancreatic neoplasms. In: Blake MA, Kalra MK (eds) Imaging in oncology. Springer, NY, pp 229–254Google Scholar
  7. 7.
    Tummala P, Junaidi O, Agarwal B (2011) Imaging of pancreatic cancer: an overview. J Gastrointest Oncol 2:168–174.  https://doi.org/10.3978/j.issn.2078-6891.2011.036
  8. 8.
    Freelove R, Walling AD (2006) Pancreatic cancer diagnosis and management. Am Fam Physician 73(3):485–493PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.2nd Department of SurgeryNational and Kapodistrian University of Athens School of MedicineAthensGreece

Personalised recommendations